Lexicon Pharmaceuticals Inc to Provide Update on Sotagliflozin Program from EASD Conference Call

13/9/2017 8:00

Conference Call Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc Conference call or earnings call will be held on Sep 13, 2017
During the earnings conference call’s session, Lexicon Pharmaceuticals Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact Lexicon Pharmaceuticals Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
Lexicon Pharmaceuticals is a biopharmaceutical company focused on the development of breakthrough treatments for human disease. We have advanced multiple drug candidates into clinical development and are presently devoting most of our resources to the development of our two most advanced drug candidates: * We are developing telotristat etiprate, or LX1032, an orally-delivered small molecule drug candidate, as a treatment for carcinoid syndrome. We have reported positive top-line data from both our pivotal TELESTAR Phase 3 clinical trial and its companion TELECAST Phase 3 clinical trial of telotristat etiprate in carcinoid syndrome patients. We are presently preparing an application for regulatory approval to market telotristat etiprate in the United States and, if approved, for the commercial launch of telotristat etiprate in the United States.    
Read more Conference Call

Lexicon Pharmaceuticals Inc (LXRX)

8800 Technology Forest Place, The Woodlands Texas 77381, United States